Cargando…
Research advances of N6‐methyladenosine in diagnosis and therapy of pancreatic cancer
BACKGROUND: N6‐methyladenosine (m6A) is the addition of a methyl group on the N6 position of adenosine and is the most prevalent and abundant epigenetic modification in eukaryote mRNA. m6A marks are added to mRNA by the m6A methyltransferase complex (“writers”), removed by m6A demethylases (“erasers...
Autores principales: | Chen, Sai, Ren, Hefei, Zhang, Xiaomin, Chang, Liu, Wang, Zhenhua, Wu, Hongkun, Zhang, Jiafeng, Ren, Jigang, Zhou, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459282/ https://www.ncbi.nlm.nih.gov/pubmed/35837987 http://dx.doi.org/10.1002/jcla.24611 |
Ejemplares similares
-
m(5)C Regulator-mediated methylation modification clusters contribute to the immune microenvironment regulation of multiple myeloma
por: Ren, Hefei, et al.
Publicado: (2022) -
Research Progress of N6-Methyladenosine in the Cardiovascular System
por: Zheng, Nan, et al.
Publicado: (2020) -
Role of N(6)-methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)
por: Ye, Tong, et al.
Publicado: (2022) -
The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022) -
The Roles of N(6)-Methyladenosine in Human
Diseases
por: An, Shanshan, et al.
Publicado: (2019)